Tailored Messaging in Colorectal Cancer Screening
结直肠癌筛查中的定制消息传递
基本信息
- 批准号:6925394
- 负责人:
- 金额:$ 14.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-21 至 2006-12-31
- 项目状态:已结题
- 来源:
- 关键词:behavioral /social science research tagcancer preventionclinical researchcolorectal neoplasmscooperative studydata collection methodology /evaluationdecision makingearly diagnosisendoscopyfocus groupsgender differencehealth behaviorhealth care policyhealth care service availabilityhealth care service utilizationhealth services research taghuman middle age (35-64)human old age (65+)information disseminationneoplasm /cancer diagnosisneoplasm /cancer educationnursing interventionprimary care physicianquestionnairesracial /ethnic differencesocial support network
项目摘要
DESCRIPTION (provided by applicant) Screening can reduce the colorectal cancer (CRC) burden but remains underutilized in primary care. In the proposed study, tailored messaging will be used to encourage FOBT and endoscopic screening in 14 primary care practices that are part of the Christiana Care Health System in Delaware. Using a quasi-experimental pretest-posttest design, we will deliver a Tailored Screening Intervention or TSI (a tailored screening kit, a tailored telephone call, and a tailored reminder letter) to patients who complete a Baseline Survey. Participants will be sent a kit containing a tailored CRC screening invitation letter and two tailored message pages that reflect their perceptions about screening FOBT and flexible sigrnoidoscopy and screening decision stage. An informational booklet on CRC screening and FOBT cards with instructions will also be included. A trained nurse educator will deliver a tailored telephone call to patients 10 days after the kit is mailed. During the call, the nurse educator will confirm receipt of mailed materials, verify current decision stage, review deliver tailored messages, determine current decision stage, encourage positive movement in decision stage, provide tailored messages keyed to decision stage, explain steps involved in FOBT and endoscopy screening, and offer to schedule endoscopy screening. For patients who do not report that they have decided to screen, the nurse educator will recommend that they discuss screening with their primary care physician. At 30 days, a tailored reminder letter will be sent to patients who have not screened or who have not scheduled screening and to their primary physician. The letter will provide current tailored messages, encourage positive movement in decision stage, and suggest physician-patient discussion of screening. An Endpoint Survey will be administered and an Endpoint Chart Audit will be conducted. Primary study aims are to: 1. Determine intervention impact on CRC screening utilization, 2. Determine intervention impact on screening decision stage, and 3. Determine intervention impact on patient perceptions about screening.
描述(由申请人提供)筛查可以减少结直肠癌(CRC)的负担,但在初级保健中仍然没有得到充分利用。在拟议的研究中,量身定制的信息将用于鼓励FOBT和内窥镜筛查在14个初级保健的做法,是特拉华州的克里斯蒂娜保健卫生系统的一部分。使用准实验性的前测-后测设计,我们将向完成基线调查的患者提供量身定制的筛查干预或TSI(量身定制的筛查工具包、量身定制的电话和量身定制的提醒信)。将向参与者发送一个工具包,其中包含定制的CRC筛选邀请函和两个定制的信息页,反映他们对筛选FOBT和灵活的sigrnoidoscopy和筛选决策阶段的看法。还将包括一本关于CRC筛查和FOBT卡的信息手册。一个受过训练的护士教育者将提供一个定制的电话给病人10天后,包邮寄。在电话会议期间,护士教育者将确认收到邮寄的材料,验证当前的决策阶段,审查提供定制的信息,确定当前的决策阶段,鼓励决策阶段的积极运动,提供关键决策阶段的定制信息,解释FOBT和内窥镜检查的步骤,并提供安排内窥镜检查。对于未报告已决定进行筛查的患者,护士教育工作者将建议他们与初级保健医生讨论筛查问题。在第30天,将向未接受筛选或未安排筛选的患者及其主治医生发送定制提醒函。这封信将提供当前定制的信息,鼓励决策阶段的积极行动,并建议医生和患者讨论筛查。将进行终点调查,并进行终点图表稽查。研究的主要目的是:1。确定干预对CRC筛查利用的影响,2.确定干预对筛选决策阶段的影响; 3.确定干预对患者对筛查的看法的影响。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD E. MYERS其他文献
RONALD E. MYERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD E. MYERS', 18)}}的其他基金
Provider Support and Patient Outreach in Lung Cancer Screening
肺癌筛查中的提供者支持和患者外展
- 批准号:
10446777 - 财政年份:2022
- 资助金额:
$ 14.44万 - 项目类别:
Provider Support and Patient Outreach in Lung Cancer Screening
肺癌筛查中的提供者支持和患者外展
- 批准号:
10600049 - 财政年份:2022
- 资助金额:
$ 14.44万 - 项目类别:
Tailored Messaging in Colorectal Cancer Screening
结直肠癌筛查中的定制消息传递
- 批准号:
6769044 - 财政年份:2004
- 资助金额:
$ 14.44万 - 项目类别:
Increasing Colon Cancer Screening in Primary Care
增加初级保健中的结肠癌筛查
- 批准号:
6778226 - 财政年份:2001
- 资助金额:
$ 14.44万 - 项目类别:
Increasing Colon Cancer Screening in Primary Care
增加初级保健中的结肠癌筛查
- 批准号:
6514267 - 财政年份:2001
- 资助金额:
$ 14.44万 - 项目类别:
Increasing Colon Cancer Screening in Primary Care
增加初级保健中的结肠癌筛查
- 批准号:
6331956 - 财政年份:2001
- 资助金额:
$ 14.44万 - 项目类别:
相似海外基金
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10425188 - 财政年份:2021
- 资助金额:
$ 14.44万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10683047 - 财政年份:2021
- 资助金额:
$ 14.44万 - 项目类别:
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
合同名称 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10223848 - 财政年份:2020
- 资助金额:
$ 14.44万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10452466 - 财政年份:2019
- 资助金额:
$ 14.44万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10894578 - 财政年份:2019
- 资助金额:
$ 14.44万 - 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10425187 - 财政年份:2019
- 资助金额:
$ 14.44万 - 项目类别:
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
合同名称 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10045660 - 财政年份:2019
- 资助金额:
$ 14.44万 - 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10691840 - 财政年份:2019
- 资助金额:
$ 14.44万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10045662 - 财政年份:2019
- 资助金额:
$ 14.44万 - 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10045663 - 财政年份:2019
- 资助金额:
$ 14.44万 - 项目类别: